NCT05101551
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05101551
Title Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy (PARPAML)
Acronym PARPAML
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Norman J. Lacayo
Indications
Therapies
Age Groups: adult | child
Covered Countries USA


No variant requirements are available.